Company Comparison
Millendo Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Millendo Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Millendo Therapeutics
Clinical-stage biopharmaceutical company developing treatments for rare endocrine diseases and hormonal disorders, ceased operations in 2021.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Millendo Therapeutics
Sector Overlap
Both Millendo Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.